EZH2 and B-cell chronic lymphocytic leukemia: In more detail, we found that EZH2 was highly expressed in a subgroup of patients (subset #1) [15], characterized by a stereotyped B cell receptor (BcR) with unmutated immunoglobulin heavy variable genes (U-CLL) and an aggressive disease course [17, 18].